Bayer AG is expanding its recently established Precision Health unit beyond the US and Europe, starting with the launch of its Aspirin Heart Risk Assessment tool in Saudi Arabia.
“Cardiovascular diseases (CVDs) pose a significant burden globally, and the Middle East is no exception,” commented Bayer’s vice president of...




